Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

Conditions:   Cystic Fibrosis;   Methicillin-resistant Staphylococcus AureusInterventions:   Drug: Rifampin;   Drug: Trimethoprim/Sulfamethoxazole;   Drug: Minocycline;   Drug: Mupirocin;   Drug: chlorhexidine gluconate oral rinse;   Drug: 2% Chlorhexidine solution wipes;   Behavioral: Environmental DecontaminationSponsors:   University of North Carolina, Chapel Hill;   CF Therapeutics Development Network Coordinating Center;   Seattle Children's Hospital;   Washington University School of Medicine;   University of Washington;   St. Louis Childrens' Hospital;   University of Colorado, Denver;   Baylor College of Medicine;   University of Alabama at Birmingham;   Cook Children's Medical Center;   University of Michigan;   University of Florida;   University of Texas Southwestern Medical Center;   Children's Hospital Medical Center, CincinnatiActive, not recruiting - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials